We use cookies to help you navigate efficiently and perform certain functions. You will find detailed information about all cookies under each consent category below.
The cookies that are categorized as "Necessary" are stored on your browser as they are essential for enabling the basic functionalities of the site. ...
Necessary cookies are required to enable the basic features of this site, such as providing secure log-in or adjusting your consent preferences. These cookies do not store any personally identifiable data.
Functional cookies help perform certain functionalities like sharing the content of the website on social media platforms, collecting feedback, and other third-party features.
Analytical cookies are used to understand how visitors interact with the website. These cookies help provide information on metrics such as the number of visitors, bounce rate, traffic source, etc.
Performance cookies are used to understand and analyze the key performance indexes of the website which helps in delivering a better user experience for the visitors.
Advertisement cookies are used to provide visitors with customized advertisements based on the pages you visited previously and to analyze the effectiveness of the ad campaigns.
Adults suffering from acute ischemic stroke are advised to consider tenecteplase as a therapy option by the National Institute for Health and Care Excellence (NICE). This choice represents a major advancement in the treatment of strokes and may have a big effect on patient care and NHS budget. Boehringer Ingelheim’s Tenecteplase, also marketed under the...
An innovative project focused on creating cutting-edge precision medicine (PM) and artificial intelligence (AI) strategies for the treatment and management of multiple sclerosis (MS) has been generously funded with AU$2.9 million (roughly $1.96 million USD) by the Australian government’s Medical Research Future Fund (MRFF). With a multidisciplinary approach, this innovative study will be led by...